Global Fund to resume suspended grants to China

NewsGuard 100/100 Score

The Global Fund to Fight AIDS, Tuberculosis and Malaria, which "froze disbursements of its AIDS grant to China in November and all other grants in May over suspected misuse of the money and the government's reluctance to involve community groups, ... said Tuesday that it was lifting the freeze on financing to ensure that AIDS work in China continued while it worked with government officials, representatives from United Nations agencies and private groups to resolve the dispute," the Associated Press reports.

"'China and The Global Fund will continue to work closely together to tighten fiduciary controls and ensure that programs are as effective as possible in combatting the three diseases,' [Global Fund spokesperson Jon] Liden said. He said the lifting was effective immediately," the AP notes. "Resolving the problem could mean China will continue to receive payments of $300 million in funding over the next several years for programs to prevent and treat" HIV/AIDS, malaria and tuberculosis, "unless the recent talks resulted in a reduction of the funding," according to the AP (8/23).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New malaria vaccine strain shows promise in preclinical trials